BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24817204)

  • 21. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
    Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaginal Microbiome of Pregnant Indian Women: Insights into the Genome of Dominant Lactobacillus Species.
    Mehta O; Ghosh TS; Kothidar A; Gowtham MR; Mitra R; Kshetrapal P; Wadhwa N; Thiruvengadam R; ; Nair GB; Bhatnagar S; Das B
    Microb Ecol; 2020 Aug; 80(2):487-499. PubMed ID: 32206831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaginal microbiota profile at the time of embryo transfer does not affect live birth rate in IVF cycles with donated oocytes.
    Vergaro P; Tiscornia G; Barragán M; García D; Rodriguez A; Santaló J; Vassena R
    Reprod Biomed Online; 2019 Jun; 38(6):883-891. PubMed ID: 30879910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial vaginosis-associated vaginal microbiota is an age-independent risk factor for Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis infections in low-risk women, St. Petersburg, Russia.
    Shipitsyna E; Khusnutdinova T; Budilovskaya O; Krysanova A; Shalepo K; Savicheva A; Unemo M
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1221-1230. PubMed ID: 32036466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal Assessment of Systemic and Genital Tract Inflammatory Markers and Endogenous Genital Tract E. coli Inhibitory Activity in HIV-Infected and Uninfected Women.
    Keller MJ; McGinn AP; Lo Y; Huber A; Espinoza L; Minkoff H; Colie C; Nowicki MJ; D'Souza G; Anastos K
    Am J Reprod Immunol; 2016 Jun; 75(6):631-42. PubMed ID: 27145926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of hydrogen peroxide-producing Lactobacillus species in the vagina: a comparison of culture and quantitative PCR among HIV-1 seropositive women.
    Balkus JE; Mitchell C; Agnew K; Liu C; Fiedler T; Cohn SE; Luque A; Coombs R; Fredricks DN; Hitti J
    BMC Infect Dis; 2012 Aug; 12():188. PubMed ID: 22889380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis.
    Hoang T; Toler E; DeLong K; Mafunda NA; Bloom SM; Zierden HC; Moench TR; Coleman JS; Hanes J; Kwon DS; Lai SK; Cone RA; Ensign LM
    PLoS Pathog; 2020 Jan; 16(1):e1008236. PubMed ID: 31971984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct Effects of the Cervicovaginal Microbiota and Herpes Simplex Type 2 Infection on Female Genital Tract Immunology.
    Shannon B; Gajer P; Yi TJ; Ma B; Humphrys MS; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Shahabi K; Ravel J; Kaul R
    J Infect Dis; 2017 May; 215(9):1366-1375. PubMed ID: 28201724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contraceptive rings promote vaginal lactobacilli in a high bacterial vaginosis prevalence population: A randomised, open-label longitudinal study in Rwandan women.
    Crucitti T; Hardy L; van de Wijgert J; Agaba S; Buyze J; Kestelyn E; Delvaux T; Mwambarangwe L; De Baetselier I; Jespers V;
    PLoS One; 2018; 13(7):e0201003. PubMed ID: 30036385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Wagner-Döbler I
    Microbiome; 2017 Aug; 5(1):99. PubMed ID: 28807017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sexual debut on vaginal microbiota in a cohort of young women.
    Mitchell CM; Fredricks DN; Winer RL; Koutsky L
    Obstet Gynecol; 2012 Dec; 120(6):1306-13. PubMed ID: 23168754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial colonization and beta defensins in the female genital tract in HIV infection.
    Jiang W; Ghosh SK; Flyckt R; Kalinowska M; Starks D; Jurevic R; Weinberg A; Lederman MM; Rodriguez B
    Curr HIV Res; 2012 Sep; 10(6):504-12. PubMed ID: 22716110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free glycogen in vaginal fluids is associated with Lactobacillus colonization and low vaginal pH.
    Mirmonsef P; Hotton AL; Gilbert D; Burgad D; Landay A; Weber KM; Cohen M; Ravel J; Spear GT
    PLoS One; 2014; 9(7):e102467. PubMed ID: 25033265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of a sensitive system for analysis of human vaginal microbiota on the basis of rRNA-targeted reverse transcription-quantitative PCR.
    Kurakawa T; Ogata K; Tsuji H; Kado Y; Takahashi T; Kida Y; Ito M; Okada N; Nomoto K
    J Microbiol Methods; 2015 Apr; 111():93-104. PubMed ID: 25661498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diversity of cervicovaginal microbiota associated with female lower genital tract infections.
    Ling Z; Liu X; Chen X; Zhu H; Nelson KE; Xia Y; Li L; Xiang C
    Microb Ecol; 2011 Apr; 61(3):704-14. PubMed ID: 21287345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between vaginal pathogenic community and bacterial vaginosis in Chinese reproductive-age women.
    Ling Z; Liu X; Luo Y; Wu X; Yuan L; Tong X; Li L; Xiang C
    PLoS One; 2013; 8(10):e76589. PubMed ID: 24124575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of rhesus macaque genital microbiota by 16S pyrosequencing shows similarities to human bacterial vaginosis: implications for use as an animal model for HIV vaginal infection.
    Spear GT; Gilbert D; Sikaroodi M; Doyle L; Green L; Gillevet PM; Landay AL; Veazey RS
    AIDS Res Hum Retroviruses; 2010 Feb; 26(2):193-200. PubMed ID: 20156101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilization of molecular methods to identify prognostic markers for recurrent bacterial vaginosis.
    Hilbert DW; Smith WL; Paulish-Miller TE; Chadwick SG; Toner G; Mordechai E; Adelson ME; Sobel JD; Gygax SE
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):231-42. PubMed ID: 27431434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis.
    Happel AU; Kullin B; Gamieldien H; Wentzel N; Zauchenberger CZ; Jaspan HB; Dabee S; Barnabas SL; Jaumdally SZ; Dietrich J; Gray G; Bekker LG; Froissart R; Passmore JS
    PLoS Pathog; 2020 Jun; 16(6):e1008559. PubMed ID: 32497109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lactobacillus species isolated from vaginal secretions of healthy and bacterial vaginosis-intermediate Mexican women: a prospective study.
    Martínez-Peña MD; Castro-Escarpulli G; Aguilera-Arreola MG
    BMC Infect Dis; 2013 Apr; 13():189. PubMed ID: 23617246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.